Nastya Kassir

14PUBLICATIONS
37CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 08, 2026
Population Pharmacokinetic Analysis of Vixarelimab in Healthy Volunteers and Patients With Chronic Pruritic Conditions.

Fei Tang, Steve Dang, Audrey Arjomandi

|Feb 17, 2026
Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations.

Joseph Chen, Russ Wada, Nancy Zhang

|May 22, 2025
Population Pharmacokinetics and Exposure-Response Relationships of Etrolizumab in Patients with Moderately-to-Severely Active Crohn's Disease.

Anita Moein, Jakob Ribbing, Moustafa M A Ibrahim

|Apr 18, 2025
Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes.

Jiawen Zhu, Amy Schroeder, Sabine Frank

|Apr 02, 2025
Mechanistic Physiologically Based Pharmacokinetic Modeling of Dry Powder and Nebulized Formulations of Orally Inhaled TMEM16A Potentiator GDC-6988.

Rui Zhu, Ian Sorrell, Fang Ma

|Mar 14, 2024
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.

Christine Bowman, Michael Dolton, Fang Ma

Pageof 3

Frequent Collaborators

2 joint publications

Meina Tang

2 joint publications

Anita Moein

2 joint publications

Yuan Chen

2 joint publications

Fang Ma